The LITE Study: The Promise of Home Phototherapy

The LITE Study: The Promise of Home Phototherapy

From Inside GRAPPA by GRAPPA Network

April 1, 2025 · 25 min · Episode 16

About this episode

Dr. Joel Gelfand discusses the LITE Study, a trial comparing home-based and office-based phototherapy for psoriasis.

In this episode of Inside GRAPPA, Dr. Joel Gelfand joins host Mio Nakamura to discuss a groundbreaking pragmatic trial that may transform access to phototherapy. A long-standing GRAPPA member and trailblazer in dermatologic research, Dr. Gelfand shares insights from the "LITE Study," a patient-centered, nationwide trial comparing home-based vs. office-based phototherapy for psoriasis. You'll hear:    •   Why phototherapy remains a preferred treatment for many patients, even in the biologic era    •   Surprising results comparing office phototherapy to adalimumab (a biologic) in previous trials    •   How skin of color patients may benefit most from home phototherapy---and why    •   Real-world barriers to accessing phototherapy and how the study tackled them head-on    •   What's next: From research findings to implementation science and changing payer coverage This episode is essential listening for dermatologists, rheumatologists, and researchers passionate about improving access and outcomes for patients with psoriatic disease…

People in this episode

Host: Mio Nakamura

Guest: Dr. Joel Gelfand

Topics covered

  • phototherapy
  • psoriasis
  • clinical research
  • patient advocacy
  • healthcare access

Keywords

  • LITE Study
  • home phototherapy
  • office phototherapy
  • psoriatic disease
  • clinical trial
  • patient-centered research
  • dermatology

Mentioned in this episode

Organizations: GRAPPA, PCORI

Products: adalimumab

More episodes of Inside GRAPPA

Explore listener stats, chart rankings, contacts and more on the Inside GRAPPA podcast page.